Answers are grounded in this paper and cite their sources.
A new concept for treatment of infections is induction of our own antimicrobial peptides and the presented novel class of inducer, aroylated phenylenediamines (APDs), gives up to 20 to 30-fold induction of the human antimicrobial peptide LL-37, in vitro. In addition, oral administration of an APD in a rabbit model of Shigellosis resulted in recovery from the infection in a few days implying that APD's are promising candidates for treatment of infections.
No takes yet. Share an insight, caveat, or question.
Ottosson et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: